18/10/2005 - Chiron has warned it will yet again fall short of targets for its US flu vaccine deliveries this year due to continuing production problems with its British manufacturing plant.
Speaking on a conference call on Monday, Chiron's chief executive Howard Pien said the plant would produce fewer than 18 million doses of flu vaccine for the 2005–06 flu season, down from a previous estimate of between 18 and 26 million doses.
In an average year in the US, influenza causes more than 200,000 hospitalisations and kills approximately 36,000 people, primarily in the over-65 population.
Influenza vaccination is the most effective way to prevent influenza.
link to full article from in-pharmatech
Friday, October 21, 2005
Chiron misses flu vaccine production target again
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment